Clinical outcomes in patients with Parkinson’s disease treated with a monoamine oxidase type-B inhibitor (MAOB-I): a cross-sectional study.

140E.

  • Chen, Jack J. Pharm.D.
  • Dashtipour, Khashayar M.D., Ph.D.
  • Bahjri, Khaled M.D., MPH

  • (1)Loma Linda University, Loma Linda, CA; (2)School of Public Health, Loma Linda University, Loma Linda, CA

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 34(10):p e213, October 2014.
Copyright © Pharmacotheraphy Publications, Inc. All rights reserved.